Biểu đồ giá cổ phiếu HIND
HIND Thu nhập
Vyome Holdings Inc
$2.1
-4.54%
$-0.1
Khi đóng cửa: May 07, 16:00:00 GMT-4
$2.08
-0.53%
$-0.01
Phiên sau giờ: May 07, 20:00:00 GMT-4
Quay lại
Vyome Holdings Inc (HIND) Thu nhập
Thống kê chính
Giá đóng cửa trước
$2.2
Giá mở cửa
$2.19
Phạm vi ngày
$2.08 - $2.21
Phạm vi 52 tuần
$1.75 - $46.6
Khối lượng
6.1K
Khối lượng trung bình
597.7K
Tỷ suất cổ tức
--
EPS (TTM)
63.63
Vốn hóa thị trường
$14.6M
HIND là gì?
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
